Factsheet – EU delivering on rare diseases for patients and families

Overview of how the European Union supports patients with rare diseases through coordinated policy, research, and healthcare collaboration.

This factsheet presents the European Union’s actions to improve the lives of people living with rare diseases and their families. It outlines key areas of work, including strengthening European Reference Networks (ERNs), supporting research and innovation, improving access to diagnosis and treatment, and enhancing cooperation across Member States.

The document also highlights recent achievements and ongoing initiatives aimed at improving healthcare systems, data sharing, and patient support across Europe.

Acces this publication
Factsheet - EU delivering on rare diseases for patients and families

Year of publication

2026

Source

European Commission – Directorate-General for Health and Food Safety

Author

Directorate-General for Health and Food Safety (European Commission)

You might also be interested in

Irish Presidency of the EU in 2026

Why Rare Diseases Matter for Europe’s Future Embedding Research and Innovation as Standard of Care in Rare Disease

October 2 @ 10:00 am - 5:15 pm
On 13 November 2026 in Dublin, Ireland, this event will explore how research, innovation, patient partnership and EU policy can improve rare disease care and strengthen Europe’s life sciences ecosystem.
European Medicines Agency (EMA)

EMA launches a new pilot to advance innovative methods to animal testing

The voluntary data submission framework allows developers to share data generated using New Approach Methodologies outside marketing authorisation applications and receive tailored, non-binding feedback from European regulatory experts.
ERDERA Knowledge Exchange Meeting

ERDERA Knowledge Exchange Meeting on Drug Repurposing for Rare Diseases

November 25 - November 26
Discover practical pathways to repurpose medicines for rare diseases, exchange experiences and best practices between underrepresented and high-performing countries, and build new partnerships at the ERDERA Knowledge Exchange Meeting in Riga on 25-26 November.
ERDERA clinical trial call

ERDERA Clinical Trial Call – Annex IV. Guidelines for Canadian Applicants

This annex explains the specific eligibility, sponsorship, funding and application requirements for Canadian applicants in the ERDERA Clinical Trial Call.

ERDERA Search